Skip to content

Contingency Management for Recovery Oriented Activities at Recovery Houses

Contingency Management for Recovery Oriented Activities at Recovery Houses

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05585203
Enrollment
120
Registered
2022-10-18
Start date
2022-10-01
Completion date
2024-09-20
Last updated
2024-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use Disorders

Keywords

contingency management, Rural recovery houses

Brief summary

In this study, the investigators will implement contingency management at rural recovery houses, where individuals with substance use disorders reside. Contingency management is a behavioral intervention in which participants receive incentives (rewards) when they complete planned tasks that are consistent with their recovery efforts. House staff members will also participate in this study and will be trained to provide contingency management to residents. The investigators will compare recovery houses that implement contingency management to matched houses that do not, and the main outcomes will be engagement in the planned activities and retention in the recovery houses. Participants will receive contingency management for up to 12 weeks and follow-up will occur 6 months post-treatment.

Interventions

BEHAVIORALContingency management

The investigators will implement a prize-based contingency management protocol in which residents will complete three pre-planned recovery-oriented activities each week for a period of up to 12 weeks. Upon verified completion of the activities each week, participants may earn prize incentives through drawing from a prize fishbowl or spinning a virtual prize wheel. Prizes will be money added to a debit card. On the first week and individual has completed pre-planned activities, s/he can receive up to 1 draw per activity completed (3 total), and each week the number of prize draws per activity will escalate by 1. If a participant fails to complete any activities, he/she will not receive the draws for the uncompleted activities, and the prize draws would be reset to 1 in the next week. Participants can earn up to $75 in incentives in total.

BEHAVIORALUsual Care

Participants in this arm will receive usual care that they would normally receive at the recovery houses. Recovery residences vary considerably, this form of housing benefits individuals in recovery by reinforcing a substance-free lifestyle and providing direct connections to other peers in recovery, mutual support groups and recovery support services.

Sponsors

Wayne State University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

A quasi-experimental design will be used. Half of the recovery houses residents will be randomly assigned to receive training in and to conduct contingency management. The other half will receive no additional training or interventions (usual care).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age 18 or older; 2. a resident of the recovery house; and 3. able to provide informed consent.

Exclusion criteria

1. expected to be discharged from the recovery house in the next two months; 2. experiencing uncontrolled mania, psychosis or suicidality.

Design outcomes

Primary

MeasureTime frameDescription
Treatment retentionTime until leaving the recovery home from study baseline up to one yearLength of time (in days) a resident resides in the recovery house
Engagement in recovery-oriented activitiesup to 12 week treatmentParticipants will engage in up to 3 planned recovery activities (noted on a tracking form)

Secondary

MeasureTime frameDescription
Self-Reported HealthBaseline, post-treatment (week 12) and 6-month follow upShort Form 36 (SF-36) is a brief measure of overall self-reported health. Scores range from 0 (maximum disability) to 100 (no disability)
Patient Health Questionnaire - 9Baseline, post-treatment (week 12) and 6-month follow upA measure of depression symptoms. Scores on the PHQ 9 range from 0 (no depression) to 27 (severe depression).
Treatment SatisfactionPost-treatment (Week 12)Treatment Satisfaction Questionnaire (Scores range from 1 to 7 with higher scores reflecting greater satisfaction)
Timeline Follow-back for substance useBaseline, weekly for 12 weeks, post-treatment (week 12) and 6-month follow upTimeline Follow-back (TLFB) is a self-report, calendar-based measure of the frequency of substance use
Treatment FeasibilityBaselineTreatment Feasibility will assessed as the proportion of eligible participants who are willing to participate after initial screening.
Substance UseBaseline, weekly for 12 weeks, post-treatment (week 12) and 6-month follow upUrine drug screen of metabolites for cocaine, methamphetamine, barbiturates, opioids, cannabis, alcohol and benzodiazepines
Quality of Life AssessmentBaseline, post-treatment (week 12) and 6-month follow upSelf-report Quality of Life inventory (scores range from -3 to 3 with higher scores reflecting greater quality of life)

Countries

United States

Contacts

Primary ContactDavid Ledgerwood, PhD
dledgerw@med.wayne.edu313-993-1380

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026